info@seagull-health.com
SeagullHealth
语言:
search
new
Indications for Fingolimod (Fingolimod)
501
Article source: Seagull Pharmacy
Nov 05, 2025

Fingolimod is a sphingosine-1-phosphate receptor modulator, mainly used for the treatment of relapsing multiple sclerosis. Since it was first approved in the United States in 2010, it has become one of the important treatment options for multiple sclerosis.

Indications for Fingolimod (Fingolimod)

Primary Indications

Fingolimod is indicated for relapsing multiple sclerosis in patients aged 10 years and older.

Specific conditions include:

Clinically Isolated Syndrome (CIS): Refers to the first episode of neurological symptom events.

Relapsing-Remitting Disease: Characterized by distinct cycles of relapse and remission.

Active Secondary Progressive Disease: Patients who still experience disease activity during the progressive phase of the disease.

Specifications and Characteristic Features of Fingolimod (Fingolimod)

0.25 mg Hard Capsules

Capsule Body Feature: Ivory-colored and opaque.

Capsule Cap Feature: Ivory-colored and opaque.

Marking System: The capsule cap is printed with "FTY 0.25mg" in black radial printing, and the capsule body has a single black radial band.

0.5 mg Hard Capsules

Capsule Body Feature: White and opaque.

Capsule Cap Feature: Bright yellow and opaque.

Anti-Counterfeiting Mark: The capsule cap is printed with the marking "FTY 0.5mg", and the capsule body has two radial bands printed with yellow ink.

Both specifications of capsules can be taken orally once daily, either on an empty stomach or with food.

Storage Methods for Fingolimod (Fingolimod)

Storage Conditions

Fingolimod capsules should be stored in an environment at 20°C to 25°C. Short-term storage within the range of 15°C to 30°C is allowed, but exposure to humid environments must be avoided.

Capsules should be kept in their original bottles or blister packs to prevent moisture from affecting the drug efficacy.

Patients and medical staff should take care to store the drug in a place out of the reach of children and seal it properly after each use.

The storage stability of the drug directly affects its efficacy and safety, so it must be stored and handled in strict accordance with the requirements.

Note: For internal discussion among medical personnel only. For specific medication, please consult the attending physician. Drug information may change over time. For the latest information, we recommend adding a medical consultant or consulting for free online.
Recommended Articles
How to Purchase 想Tablets (Azithromycin)
Azithromycin Tablets (Azithromycin) are a commonly used macrolide antib iotic that plays an important role in the treatment of various bacterial infections.How to Purchase Azithromycin Tablets (Azithr...
Administration of Triumeq
Triumeq is a fixed-dose combination preparation used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection.Administration of TriumeqAdult DosageThe recommended dose is one tablet ...
Indications for Triumeq
Triumeq is a fixed-dose combination preparation used for the treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection. It consists of three active ingredients: abacavir, dolutegravir, and la...
How to Purchase Triumeq
Triumeq (Abacavir, Dolutegravir and Lamivudine Tablets) is a fixed-dose combination preparation used for the treatment of HIV-1 infection, containing three active ingredients: abacavir, dolutegravir, ...
How to Use Fingolimod (Fingolimod)
Fingolimod is a sphingosine-1-phosphate receptor modulator, primarily indicated for the treatment of relapsing multiple sclerosis in patients aged 10 years and older, including clinically isolated syn...
Precautions for Administration of Fingolimod (Fingolimod)
Fingolimod is a sphingosine-1-phosphate receptor modulator. It achieves immunomodulatory treatment for multiple sclerosis by blocking the migration of lymphocytes from lymph nodes to the periphery.Pre...
What Are the Side Effects of Fingolimod (Fingolimod)?
As the first oral sphingosine-1-phosphate receptor modulator for the treatment of multiple sclerosis, fingolimod provides patients with a convenient treatment option. However, both doctors and patient...
Indications for Tivozanib Capsules (Fotivda)
Tivozanib Capsules (Fotivda) is a kinase inhibitor that was first approved in the United States in 2021. As an important drug for the treatment of advanced renal cell carcinoma, it blocks tumor angiog...
Related Articles
Dosage and Administration, Recommended Dosage of Capmatinib (Tabrecta)
Capmatinib (Tabrecta) is a highly selective MET inhibitor, offering a precision treatment option for patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutation...
What Are the Indications for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a targeted therapy medication that plays an important role in the treatment of non-small cell lung cancer associated with specific gene mutations. As a MET kinase inhibitor, i...
What Are the Purchase Channels for Capmatinib (Tabrecta)?
Capmatinib (Tabrecta) is a highly selective MET inhibitor that has demonstrated significant efficacy in patients with metastatic non-small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutat...
Adverse Reactions of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is an isocitrate dehydrogenase 1 (IDH1) inhibitor, primarily indicated for the treatment of patients with acute myeloid leukemia, myelodysplastic syndromes, and cholangiocarcinoma...
What Are the Precautions for Using Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is a targeted therapy medication primarily indicated for the treatment of patients with malignant hematologic diseases harboring specific gene mutations.What Are the Precautions f...
Dosage and Administration, Recommended Dosage of Ivosidenib (Tibsovo)
Ivosidenib (Tibsovo) is a targeted isocitrate dehydrogenase 1 (IDH1) inhibitor that demonstrates significant value in the treatment of malignant tumors with specific gene mutations.Dosage and Administ...
What Are the Indications for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an oral isocitrate dehydrogenase-1 (IDH1) inhibitor indicated for patients with various malignant tumors harboring specific IDH1 gene mutations. By inhibiting the activity of m...
What Are the Purchase Channels for Ivosidenib (Tibsovo)?
Ivosidenib (Tibsovo) is an important targeted therapy drug against IDH1 mutations, demonstrating significant efficacy in diseases such as acute myeloid leukemia and cholangiocarcinoma. For patients in...
New Drugs
Infigratinib(Truseltiq)
Infigratinib(Truseltiq)
Treatment of previously treated, unresectable locally advanced or metastatic...
Opicapone(Ongentys)
Opicapone(Ongentys)
Adjunctive treatment to levodopa/carbidopa for reducing "off" episodes in...
Deflazacort(Emflaza)
Deflazacort(Emflaza)
Treatment of Duchenne muscular dystrophy (DMD) in patients aged 2 years and...
Faricimab-svoa(Vabysmo)
Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular...
Counselling Service
Global Drug Search
Clinical Research Recruitment
Overseas Medical Treatment
Remote Consultations
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Submit
Business
  • Core products
  • Antitumor drugs
  • General drug
  • Antiviral drugs
  • Biological agents
Contact Us 
  • mailbox:info@lucius.la
Welcome to consult
ucius Pharmaceuticals (Lao) Co.,Ltd All rights reserved